AMSA Pharm-free Scorecard 2010
F Louisiana State University School of Medicine - Shreveport
City: Shreveport State: LA
Links:
Commentary:

LSU-Shreveport submitted updated but incomplete policies for the 2012-3 Scorecard evaluation. This institution could still implement a number of improvements across numerous domains. There was improvement in the disclosure policy, inclusion of curriculum regarding conflict of interest as well as implementation an oversight committee. Their grade due to the minor improvements in their prior policy remains an F.

 

This institution has not granted permission for the posting of their policies on this website for illustrative purposes.


This institution's evaluation was last updated: 4/9/2013.



Gifts & Meals 1
Consulting relationships 1
Industry-funded speaking relationships 1
Disclosure 2 The management plan and/or the COI Committee can include public disclosure, though it is not mandated.
Pharmaceutical samples 1
Purchasing & Formularies 1
Industry Sales Representatives 1
On-campus Education 1
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 1
Industry Support for Scholarships & Funds for Trainees 1
Medical school curriculum 2 The faculty and staff will be trained in just the policy, not the rationale behind the policies.
Do the policies specify an oversight mechanism? Yes The Department of Legal Affairs and Organizational Integrity is responsible for managing records and oversight.
Are there explicit sanctions for noncompliance? No
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)